A systematic review of sixteen studies finds that emerging serum and urine protein biomarkers, including PHI, PSP94/PSA ratio ...

A prospective study of 24 men found that 18F-Flotufolastat PSMA PET MRI detected recurrent prostate cancer in 25 percent of ...

In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18 F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active disease as ...

Newswise — A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA ...

Extended follow-up data from the ProtecT trial highlight the importance of weighing the risks associated with radical treatment versus active surveillance for newly diagnosed localized prostate cancer ...

CINCINNATI A new study supports the use of a DNA-based "biomarker blood test as a complement to the prostate-specific antigen (PSA) test currently offered to screen men for prostate cancer. University ...

Digital rectal examination (DRE) is neither helpful nor useful as a solitary prostate cancer screening tool in middle-aged men, say investigators reporting the PROBASE study. The study compared ...

Paclitaxel Decreases the Interstitial Fluid Pressure and Improves Oxygenation in Breast Cancers in Patients Treated With Neoadjuvant Chemotherapy: Clinical Implications From our prostate cancer ...

Among men with PSA persistence after radical prostatectomy, a higher preoperative PSA surprisingly was linked to lower mortality. Men with PSA persistence and preoperative PSA >20 ng/mL had 31% lower ...

Reston, VA—In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18 F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active ...

Among men who had persistent prostate-specific antigen (PSA) after radical prostatectomy (RP), a higher preoperative PSA ...